Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Picornavirus inhibitors

L Carrasco1

  • 1Centro de Biologia Molecular, Universidad Autonoma, Madrid, Spain.

Pharmacology & Therapeutics
|January 1, 1994
PubMed
Summary
This summary is machine-generated.

Picornaviruses, a family of important animal and human pathogens, are molecularly well-understood. Inhibitors of these viruses aid in understanding their biology and show therapeutic promise.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Immunopathogenesis of lung lesions induced by the highly virulent Rosalía strain of PRRSV-1 circulating in Spain since 2020.

Veterinary journal (London, England : 1997)·2026
Same author

Time Series Transcriptomic Analysis of Bronchoalveolar Lavage Cells from Piglets Infected with Virulent or Low-Virulent Porcine Reproductive and Respiratory Syndrome Virus 1.

Journal of virology·2021
Same author

The jigsaw of PRRSV virulence.

Veterinary microbiology·2021
Same author

Prevalence of mycoplasma-like lung lesions in pigs from commercial farms from Spain and Portugal.

Porcine health management·2021
Same author

Activation of pro- and anti-inflammatory responses in lung tissue injury during the acute phase of PRRSV-1 infection with the virulent strain Lena.

Veterinary microbiology·2020
Same author

Reassessing the role of internalin B in Listeria monocytogenes virulence using the epidemic strain F2365.

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases·2018
Same journal

Nipocalimab and other FcRn blockers in neuromuscular disorders.

Pharmacology & therapeutics·2026
Same journal

C26:0-lysophosphatidylcholine in X-linked adrenoleukodystrophy.

Pharmacology & therapeutics·2026
Same journal

The CircRNA/miRNA axis in breast cancer: From molecular mechanisms to clinical translation.

Pharmacology & therapeutics·2026
Same journal

Glymphatic-meningeal lymphatic dysfunction in epilepsy: novel mechanistic insights and therapeutic avenues.

Pharmacology & therapeutics·2026
Same journal

The neurovascular unit under siege: Molecular mechanisms and potential drug target for cerebral edema.

Pharmacology & therapeutics·2026
Same journal

A-type potassium channels in pain signaling: Fundamental mechanisms and pathophysiological roles.

Pharmacology & therapeutics·2026
See all related articles

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Picornaviruses are a significant family of viruses causing important human and animal diseases.
  • Molecular understanding of picornaviruses is advanced.
  • Atomic resolution structures of picornavirus particles and interacting agents are available.

Purpose of the Study:

  • To review the genome organization and replication cycle of picornaviruses.
  • To summarize known inhibitors of picornavirus functions.
  • To highlight the role of structural information in drug design and therapeutic development.

Main Methods:

  • Literature review of picornavirus biology, inhibitors, and structural studies.
  • Analysis of genome organization and replication steps.

Related Experiment Videos

  • Examination of structure-based drug design approaches.

    • Main Results:

    • Picornavirus genome organization and replication are well-characterized.
    • Numerous compounds inhibiting picornavirus functions have been identified.
    • Atomic resolution structures facilitate computer-assisted drug design.
    • Some inhibitors demonstrate clinical efficacy.

    Conclusions:

    • Picornavirus inhibitors are valuable tools for studying viral biology.
    • Structural insights enable the development of novel therapeutic agents.
    • Agents targeting picornavirus particles show proven clinical efficacy.